Project Grant HT94252310078
Award Date
2/1/23
Completion Date
1/31/27
Dollars Obligated
$1.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
The Baylor College of Medicine will use a $1.6 million Project Grant from the Defense Health Agency to research germline variants and population-wide breast cancer risk. The grant was awarded on February 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). Through basic, applied, and advanced biomedical research, this project aims to transform healthcare for service members and the public by investigating medical solutions for the battlefield and developing...
This $1,600,000.00 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at Baylor College of Medicine focused on developing new synthetic lethal combination therapies targeting TopBP1 and the arachidonic acid pathway for breast cancer treatment. The three-year award, with an end date of February 28, 2027, will fund basic, translational, and clinical research aimed at advancing scientific understanding and...
This federal Project Grant award of $2,239,998.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Baylor College of Medicine to investigate the progression from ductal carcinoma in situ (DCIS) to invasive basal-like breast cancer driven by the N-RAS gene. The research project aims to advance the understanding of this disease process with the potential to lead to improved diagnostic and treatment approaches. The award...
This $1,200,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by Baylor College of Medicine to eliminate bone metastasis through a bone-targeting E-cadherin antibody nanogel. The 4-year award, effective from April 1, 2025 to March 31, 2028, aims to transform healthcare for military service members, veterans, and the broader public through innovative biomedical research. As a leading academic medical...
This federal Project Grant award of $720,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by Baylor College of Medicine to investigate "Targeting Cryptic Splicing-Derived Neoantigens in HNRNPM-Dysregulated Triple-Negative Breast Cancer". The research aims to transform healthcare for military service members, veterans, and the public by advancing innovative biomedical research across diverse medical domains. Baylor...
The federal Project Grant award of $1,597,224.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program to support the research project "BCL-XL IN BREAST CANCER METASTASIS AND THERAPY" at Baylor College of Medicine in Houston, Texas. The award, with a performance period from August 1, 2024 to July 31, 2027, will fund advanced biomedical research initiatives focused on transforming healthcare for military service...
The Baylor College of Medicine will leverage spliceosome-targeted therapies to harness the immune system against metastatic breast cancer under a $800,000 Project Grant from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program, with the CFDA number 12.420, which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for battlefield injuries and...
The U.S. Defense Health Agency awarded a $802,500 Project Grant to Baylor College of Medicine under the Military Medical Research and Development (CFDA 12.420) program. The grant supports preclinical gene therapy studies in a mouse model of TSC2, a genetic disorder, over a performance period from May 1, 2025 to April 30, 2028. As a leading academic medical institution, Baylor College of Medicine conducts diverse biomedical research and delivers specialized scientific services to federal agencies...
Baylor College of Medicine was awarded a $1.44 million Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research exploring connections between structural racism and children's health from August 1, 2023 through July 31, 2026. As the prime grantee, Baylor College of Medicine will leverage its expertise in medical research to investigate the relationship between structural racism and children's health...
This $1,200,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund Baylor College of Medicine to conduct research on precision glycocalyx editing of the metastatic bone microenvironment over a three-year period from September 15, 2023 to September 14, 2026. As a private non-profit university, Baylor College of Medicine has extensive experience managing federal grants and contracts for biomedical...